Loading clinical trials...
Loading clinical trials...
Comparing the effect of two different duration of same drug albendazole in patients with Neurocysticercosis less than or equal to 5 lesions on CT head at the end of 6 months.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
All India Institute of Medical Sciences
NCT00001205 · Cysticercosis, Neurocysticercosis
NCT03834337 · Neurocysticercosis
NCT02947581 · Neurocysticercosis
NCT02234570 · Neurocysticercosis
NCT00526916 · Neurocysticercosis, Healthy
sheffali Gulati
New Delhi, National Capital Territory of Delhi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions